Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKerry Regulatory News (KYGA)

Share Price Information for Kerry (KYGA)

Share Price is delayed by 15 minutes
Get Live Data
72.50    0.00 (0.00%)
Bid:
72.60
Ask:
73.00
Spread: 0.40 (0.551%)
Market Cap: €11.59b
KYGA Live PriceLast checked at - London Stock Exchange

Intraday Kerry Share Chart

Transaction in Own Shares

6 May 2025 07:00

RNS Number : 3263H
Kerry Group PLC
06 May 2025
 

 

 

 

6 May 2025

 

LEI: 635400TLVVBNXLFHWC59

 

KERRY GROUP PLC

Regulatory Announcement

TRANSACTION IN OWN SHARES

Kerry Group plc ("Kerry" or the "Company") announces that on Friday, May 2, 2025  it purchased the following number of its A ordinary shares of €0.125 each (the "Ordinary Shares") on Euronext Dublin from J&E Davy. The Ordinary Shares purchased will be cancelled.

Euronext Dublin

 

Number of Ordinary Shares purchased: 

13,021

 

Highest price paid per Ordinary Share:

95.0000

 

Lowest price paid per Ordinary Share:

94.7000

 

Volume weighted average price paid per Ordinary Share:

94.8440

 

 

The Ordinary Shares purchased form part of Kerry's intention to buyback Ordinary Shares of a total value of up to €300 million in the period up to 30 June 2025 ("Buyback Programme"). The intention to launch this Buyback Programme was announced on 24 October 2024 and formally commenced on 12 November 2024.

Following settlement of the above transactions and subsequent share cancellation Kerry will have  164,833,979 Ordinary Shares in issue (excluding treasury shares).

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the "Market Abuse Regulation") (including as it forms part of retained EU law in the United Kingdom ('UK') from time to time and, where relevant, pursuant to the UK's European Union (Withdrawal) Act 2018 and the UK's Market Abuse (Amendment) (EU Exit) Regulations 2019), a detailed breakdown of individual trades made by J&E Davy as riskless principal on behalf of Kerry on Euronext Dublin as part of the Buyback Programme for subsequent repurchase by the Company is scheduled to this announcement.

 

CONTACT INFORMATION

 

 

 

 

Group Secretary

 

 

 

Ronan Deasy

 

 

 

+353 66 7182000 | TraleeCoSec@kerry.ie

 

 

 

 

Website

 

 

 

www.kerry.com

 

 

 

 

 

 

Issuer name:

Kerry Group plc

 

LEI

635400TLVVBNXLFHWC59

ISIN:

IE0004906560

Intermediary name:

J&E Davy

Intermediary code:

DAVYIE21

Time zone:

GMT

Currency:

EUR

Aggregated Information

Trading venue

Currency

Volume Weighted Average Price

Aggregated volume

Euronext Dublin

EUR

94.8440

13,021

Euronext Dublin

Number ofShares

Price per Share (EUR)

Trading Venue

Time of Transaction

MatchID

6771

94.700

Euronext Dublin

 08:23:02

00044384758TRLO0-1

6250

95.000

Euronext Dublin

 10:02:39

00044387825TRLO0-1

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSATMFTMTAMBIA
Date   Source Headline
27th Oct 20227:00 amRNSQ3 Interim Management Statement 2022
7th Oct 20227:00 amRNSKerry Increases its Stake in Proparent B.V.
3rd Oct 202210:13 amRNSTotal Voting Rights
5th Sep 20221:04 pmRNSDirector/PDMR Shareholding
1st Sep 202210:08 amRNSTotal Voting Rights
30th Aug 20222:02 pmRNSKerry Acquisition Announcement
2nd Aug 202210:09 amRNSDirector/PDMR Shareholding
2nd Aug 20229:00 amRNSTotal Voting Rights
29th Jul 20227:00 amRNSKerry Group Interim Management Report 2022
1st Jul 20228:54 amRNSBlock listing Interim Review
1st Jul 20228:40 amRNSTotal Voting Rights
20th Jun 202210:23 amRNSHolding(s) in Company
1st Jun 202210:03 amRNSTotal Voting Rights
3rd May 202212:57 pmRNSTotal Voting Rights
28th Apr 20224:32 pmRNSDirectorate Change
28th Apr 20224:29 pmRNSResult of AGM
28th Apr 20227:00 amRNSQ1 Interim Management Statement 2022
4th Apr 20221:42 pmRNSStatement re Russian and Belarus Operations
1st Apr 202211:22 amRNSTotal Voting Rights
25th Mar 202212:55 pmRNSNotice of AGM
16th Mar 20221:50 pmRNSHolding(s) in Company
16th Mar 20221:39 pmRNSDirector/PDMR Shareholding
15th Mar 20224:45 pmRNSDirector/PDMR Shareholding
11th Mar 20224:03 pmRNSDirector/PDMR Shareholding
11th Mar 20223:59 pmRNSDirector/PDMR Shareholding
11th Mar 20223:55 pmRNSDirector/PDMR Shareholding
11th Mar 202212:13 pmRNSAnnual Financial Report
1st Mar 20229:50 amRNSTotal Voting Rights
25th Feb 20223:14 pmRNSDirector/PDMR Shareholding
16th Feb 20227:00 amRNSPreliminary Statement of Results 31 December 2021
15th Feb 202211:29 amRNSNotice of Results and AGM
15th Feb 20227:00 amRNSKerry – strategic biotechnology acquisitions
1st Feb 20222:21 pmRNSTotal Voting Rights
4th Jan 20223:00 pmRNSBlock listing Interim Review
4th Jan 202212:00 pmRNSTotal Voting Rights
13th Dec 202110:31 amRNSDirectorate Change
9th Dec 202112:17 pmRNSDirector/PDMR Shareholding
1st Dec 202112:26 pmRNSTotal Voting Rights
29th Nov 20211:28 pmRNSDirector/PDMR Shareholding
24th Nov 20215:41 pmRNSKerry - EUR750m Sustainability-Linked Notes
1st Nov 202111:20 amRNSTotal Voting Rights
27th Oct 20217:00 amRNSQ3 Interim Management Statement 2021
13th Oct 20217:00 amRNSKerry Strategic Update – Capital Markets Day
1st Oct 20219:20 amRNSTotal Voting Rights
27th Sep 20217:00 amRNSKerry Completes Sale of Meats & Meals Business
14th Sep 20217:00 amRNSKerry completes acquisition of Niacet
2nd Sep 202111:54 amRNSHolding(s) in Company
1st Sep 202111:22 amRNSHolding(s) in Company
1st Sep 202111:02 amRNSTotal Voting Rights
18th Aug 20214:11 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.